Leo O, Foo M, Segal D M, Shevach E, Bluestone J A
J Immunol. 1987 Aug 15;139(4):1214-22.
A new T cell molecule defined by the mAb 143-4-2 has been identified that is involved in T cell activation. The expression of the 143-4-2-defined epitope is linked to the previously characterized Ly-6 locus and restricted to bone marrow cells and to a subset of peripheral Lyt-2+ cells. In comparison to other anti-Ly-6.2 mAb, the 143-4-2 mAb appears to be directed at an allogeneic determinant of the Ly-6.2C molecule. The anti-Ly-6.2C antibody can promote the lysis of antigen-non-bearing target cells by alloreactive CTL clones, and in the presence of cofactors (PMA or IL 2) induces a subset of Lyt-2+ cells to proliferate, perhaps through an autocrine pathway. Although the antibody described has antigen-like effects as described for anti-TcR complex reagents, studies performed with a recently derived anti-murine T3 mAb suggest that the Ly-6.2C molecule is not associated on the cell surface with components of the TcR complex. Nevertheless, cell surface expression of the TcR complex is required for optimal triggering of T cells via the Ly-6.2C molecule. Because Ly-6.2C determinants are expressed in bone marrow and not in the thymus, the possibility is considered that expression of this molecule identifies a distinct subset of extrathymically derived T cells.
已鉴定出一种由单克隆抗体143-4-2所定义的新T细胞分子,它参与T细胞活化。由143-4-2所定义的表位的表达与先前已鉴定的Ly-6基因座相关联,并局限于骨髓细胞和外周Lyt-2⁺细胞的一个亚群。与其他抗Ly-6.2单克隆抗体相比,143-4-2单克隆抗体似乎针对Ly-6.2C分子的一个同种异体决定簇。抗Ly-6.2C抗体可促进同种反应性CTL克隆对不携带抗原的靶细胞的裂解,并且在辅因子(佛波酯或白细胞介素2)存在的情况下,可诱导Lyt-2⁺细胞的一个亚群增殖,可能是通过自分泌途径。尽管所述抗体具有如抗T细胞受体复合物试剂所描述的类似抗原的作用,但用最近获得的抗小鼠T3单克隆抗体进行的研究表明,Ly-6.2C分子在细胞表面不与T细胞受体复合物的成分相关联。然而,通过Ly-6.2C分子对T细胞进行最佳触发需要T细胞受体复合物在细胞表面表达。由于Ly-6.2C决定簇在骨髓中表达而不在胸腺中表达,因此认为该分子的表达可鉴定出胸腺外来源的T细胞的一个独特亚群。